Atlas Trials

Safety and Tolerability of GX-P1 in Healthy Male Volunteers

Clinical trial NCT04298749 · COMPLETED

Trial details

NCT number
NCT04298749
Sponsor
Genexine, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Autoimmune Diseases
Start date
2020-08-11
Primary completion
2021-06-07
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.